메뉴 건너뛰기




Volumn 98, Issue 8, 2013, Pages 4992-

Erratum: GH Treatment to final height produces similar height gains in patients with shox deficiency and turner syndrome: Results of a multicenter trial (Journal of Clinical Endocrinology and Metabolism (2013) 98 (E1383-E1392) DOI:10.1210/jc.2013-1222);GH treatment to final height produces similar height gains in patients with SHOX deficiency and turner syndrome: Results of a multicenter trial

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE;

EID: 84881488731     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-4040     Document Type: Erratum
Times cited : (79)

References (41)
  • 1
    • 0030940217 scopus 로고    scopus 로고
    • Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome
    • Rao E, Weiss B, Fukami M, et al. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet. 1997;16:54-63.
    • (1997) Nat Genet. , vol.16 , pp. 54-63
    • Rao, E.1    Weiss, B.2    Fukami, M.3
  • 3
    • 79951797804 scopus 로고    scopus 로고
    • Short stature due to SHOX deficiency: Genotype, phenotype, and therapy
    • Binder G. Short stature due to SHOX deficiency: genotype, phenotype, and therapy. Horm Res Paediatr. 2011;75:81-89.
    • (2011) Horm Res Paediatr. , vol.75 , pp. 81-89
    • Binder, G.1
  • 4
    • 25444470259 scopus 로고    scopus 로고
    • A novel class of Pseudoautosomal region 1 deletions downstream of SHOX is associated with Leri-Weill dyschondrosteosis
    • Benito-Sanz S, Thomas NS, Huber C, et al. A novel class of Pseudoautosomal region 1 deletions downstream of SHOX is associated with Leri-Weill dyschondrosteosis.AmJHumGenet. 2005;77:533-544.
    • (2005) AmJHumGenet. , vol.77 , pp. 533-544
    • Benito-Sanz, S.1    Thomas, N.S.2    Huber, C.3
  • 5
    • 26844470927 scopus 로고    scopus 로고
    • The phenotype of short stature homeobox gene (SHOX) deficiency in childhood: Contrasting children with Leri-Weill dyschondrosteosis and Turner syndrome
    • Ross JL, Kowal K, Quigley CA, et al. The phenotype of short stature homeobox gene (SHOX) deficiency in childhood: contrasting children with Leri-Weill dyschondrosteosis and Turner syndrome. J Pediatr. 2005;147:499-507.
    • (2005) J Pediatr. , vol.147 , pp. 499-507
    • Ross, J.L.1    Kowal, K.2    Quigley, C.A.3
  • 6
    • 33845662367 scopus 로고    scopus 로고
    • SHOX mutations in idiopathic short stature and Leri-Weill dyschondrosteosis: Frequency and phenotypic variability
    • Jorge AA, Souza SC, Nishi MY, et al. SHOX mutations in idiopathic short stature and Leri-Weill dyschondrosteosis: frequency and phenotypic variability. Clin Endocrinol (Oxf). 2007;66:130-135.
    • (2007) Clin Endocrinol (Oxf). , vol.66 , pp. 130-135
    • Jorge, A.A.1    Souza, S.C.2    Nishi, M.Y.3
  • 7
    • 34248379653 scopus 로고    scopus 로고
    • Genotypes and phenotypes in children with short stature: Clinical indicators of SHOX haploinsufficiency
    • Rappold G, Blum WF, Shavrikova EP, et al. Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiency. J Med Genet. 2007;44:306-313.
    • (2007) J Med Genet. , vol.44 , pp. 306-313
    • Rappold, G.1    Blum, W.F.2    Shavrikova, E.P.3
  • 8
    • 83255185012 scopus 로고    scopus 로고
    • Identification of the first PAR1 deletion encompassing upstream SHOX enhancers in a family with idiopathic short stature
    • Benito-Sanz S, Aza-Carmona M, Rodríguez-Estevez A, et al. Identification of the first PAR1 deletion encompassing upstream SHOX enhancers in a family with idiopathic short stature. Eur J Hum Genet. 2012;20:125-127.
    • (2012) Eur J Hum Genet. , vol.20 , pp. 125-127
    • Benito-Sanz, S.1    Aza-Carmona, M.2    Rodríguez-Estevez, A.3
  • 9
    • 0036963699 scopus 로고    scopus 로고
    • Deletions of the homeobox gene SHOX (short stature homeobox) are an important cause of growth failure in children with short stature
    • Rappold GA, Fukami M, Niesler B, et al. Deletions of the homeobox gene SHOX (short stature homeobox) are an important cause of growth failure in children with short stature. J Clin Endocrinol Metab. 2002;87:1402-1406.
    • (2002) J Clin Endocrinol Metab. , vol.87 , pp. 1402-1406
    • Rappold, G.A.1    Fukami, M.2    Niesler, B.3
  • 10
    • 81455158397 scopus 로고    scopus 로고
    • SHOX gene defects and selected dysmorphic signs in patients of idiopathic short stature and Léri-Weill dyschondrosteosis
    • Hirschfeldova K, Solc R, Baxova A, et al. SHOX gene defects and selected dysmorphic signs in patients of idiopathic short stature and Léri-Weill dyschondrosteosis. Gene. 2012;491:123-127.
    • (2012) Gene. , vol.491 , pp. 123-127
    • Hirschfeldova, K.1    Solc, R.2    Baxova, A.3
  • 12
    • 0033305653 scopus 로고    scopus 로고
    • Skeletal features and growth patterns in 14 patients with haploinsufficiency of SHOX: Implications for the development of Turner syndrome
    • Kosho T, Muroya K, Nagai T, et al. Skeletal features and growth patterns in 14 patients with haploinsufficiency of SHOX: implications for the development of Turner syndrome. J Clin Endocrinol Metab. 1999;84:4613-4621.
    • (1999) J Clin Endocrinol Metab. , vol.84 , pp. 4613-4621
    • Kosho, T.1    Muroya, K.2    Nagai, T.3
  • 13
    • 4544383265 scopus 로고    scopus 로고
    • SHOX haploinsufficiency and Leri-Weill dyschondrosteosis: Prevalence and growth failure in relation to mutation, sex, and degree of wrist deformity
    • Binder G, Renz A, Martinez A, et al. SHOX haploinsufficiency and Leri-Weill dyschondrosteosis: prevalence and growth failure in relation to mutation, sex, and degree of wrist deformity. J Clin Endocrinol Metab. 2004;89:4403-4408.
    • (2004) J Clin Endocrinol Metab. , vol.89 , pp. 4403-4408
    • Binder, G.1    Renz, A.2    Martinez, A.3
  • 14
    • 2442641275 scopus 로고    scopus 로고
    • Statural growth in 31 Japanese patients with SHOX haploinsufficiency: Support for a disadvantageous effect of gonadal estrogens
    • Fukami M, Nishi Y, Hasegawa Y, et al. Statural growth in 31 Japanese patients with SHOX haploinsufficiency: support for a disadvantageous effect of gonadal estrogens. Endocr J. 2004;51:197-200.
    • (2004) Endocr J. , vol.51 , pp. 197-200
    • Fukami, M.1    Nishi, Y.2    Hasegawa, Y.3
  • 15
    • 0035963921 scopus 로고    scopus 로고
    • Turner's syndrome
    • Ranke MB, Saenger P. Turner's syndrome. Lancet. 2001;358:309-314.
    • (2001) Lancet. , vol.358 , pp. 309-314
    • Ranke, M.B.1    Saenger, P.2
  • 16
    • 0031991527 scopus 로고    scopus 로고
    • Growth hormone therapy of Turner's syndrome: Beneficial effect on adult height
    • Rosenfeld RG, Attie KM, Frane J, et al. Growth hormone therapy of Turner's syndrome: beneficial effect on adult height. J Pediatr. 1998; 132:319-324.
    • (1998) J Pediatr. , vol.132 , pp. 319-324
    • Rosenfeld, R.G.1    Attie, K.M.2    Frane, J.3
  • 17
    • 18344393262 scopus 로고    scopus 로고
    • Growth hormone and low dose estrogen in Turner syndrome: Results of a United States multi-center trial to near-final height
    • Quigley CA, Crowe BJ, Anglin DG, Chipman JJ. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height. J Clin Endocrinol Metab. 2002;87:2033-2041.
    • (2002) J Clin Endocrinol Metab. , vol.87 , pp. 2033-2041
    • Quigley, C.A.1    Crowe, B.J.2    Anglin, D.G.3    Chipman, J.J.4
  • 18
    • 0037340318 scopus 로고    scopus 로고
    • Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens
    • van Pareren YK, de Muinck Keizer-Schrama SM, Stijnen T, et al. Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab. 2003;88:1119-1125.
    • (2003) J Clin Endocrinol Metab. , vol.88 , pp. 1119-1125
    • Van Pareren, Y.K.1    De Muinck Keizer-Schrama, S.M.2    Stijnen, T.3
  • 19
    • 15744404848 scopus 로고    scopus 로고
    • Turner syndrome and GH treatment: The state of the art
    • Pasquino AM. Turner syndrome and GH treatment: the state of the art. J Endocrinol Invest. 2004;27:1072-1075.
    • (2004) J Endocrinol Invest. , vol.27 , pp. 1072-1075
    • Pasquino, A.M.1
  • 20
    • 21244448056 scopus 로고    scopus 로고
    • Impact of growth hormone supplementation on adult height in Turner syndrome: Results of the Canadian randomized controlled trial
    • Stephure DK. Impact of growth hormone supplementation on adult height in Turner syndrome: results of the Canadian randomized controlled trial. J Clin Endocrinol Metab. 2005;90:3360-3366.
    • (2005) J Clin Endocrinol Metab. , vol.90 , pp. 3360-3366
    • Stephure, D.K.1
  • 21
    • 79953228483 scopus 로고    scopus 로고
    • Growth hormone plus childhood low-dose estrogen in Turner's syndrome
    • Ross JL, Quigley CA, Cao D, et al. Growth hormone plus childhood low-dose estrogen in Turner's syndrome. N Engl J Med. 2011;364: 1230-1242.
    • (2011) N Engl J Med. , vol.364 , pp. 1230-1242
    • Ross, J.L.1    Quigley, C.A.2    Cao, D.3
  • 22
    • 33846056188 scopus 로고    scopus 로고
    • Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: Two-year results of a randomized, controlled, multicenter trial
    • BlumWF, Crowe BJ, Quigley CA, et al. Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: two-year results of a randomized, controlled, multicenter trial. J Clin Endocrinol Metab. 2007;92: 219-228.
    • (2007) J Clin Endocrinol Metab. , vol.92 , pp. 219-228
    • Blumwf Crowe, B.J.1    Quigley, C.A.2
  • 23
    • 72749122013 scopus 로고    scopus 로고
    • Enhancer deletions of the SHOX gene as a frequent cause of short stature: The essential role of a 250 kb downstream regulatory domain
    • Chen J, Wildhardt G, Zhong Z, et al. Enhancer deletions of the SHOX gene as a frequent cause of short stature: the essential role of a 250 kb downstream regulatory domain. J Med Genet. 2009;46: 834-839.
    • (2009) J Med Genet. , vol.46 , pp. 834-839
    • Chen, J.1    Wildhardt, G.2    Zhong, Z.3
  • 26
    • 0342263158 scopus 로고
    • Evaluation of growth and development
    • Holliday MA, Barratt TM, Avner ED, Kogan BA, eds Baltimore, MD: Williams, Wilkins
    • Preece MA. Evaluation of growth and development. In: Holliday MA, Barratt TM, Avner ED, Kogan BA, eds. Pediatric Nephrology. 3rd ed. Baltimore, MD: Williams, Wilkins; 1994:378-396.
    • (1994) Pediatric Nephrology. 3rd Ed , pp. 378-396
    • Preece, M.A.1
  • 27
    • 0036965444 scopus 로고    scopus 로고
    • Achart to link child centiles of body mass index, weight and height
    • Cole TJ.Achart to link child centiles of body mass index, weight and height. Eur J Clin Nutr. 2002;56:1194-1199.
    • (2002) Eur J Clin Nutr. , vol.56 , pp. 1194-1199
    • Cole, T.J.1
  • 28
    • 7244241456 scopus 로고    scopus 로고
    • 2003 Insulin-like growth factors and their binding proteins
    • Ranke MB, ed 3rd revised and extended edition Basel, Switzerland: S. Karger
    • Blum WF, Schweizer R. 2003 Insulin-like growth factors and their binding proteins. In: Ranke MB, ed. Diagnostics of Endocrine Function in Children and Adolescents. 3rd revised and extended edition Basel, Switzerland: S. Karger; 166-199.
    • Diagnostics of Endocrine Function in Children and Adolescents , pp. 166-199
    • Blum, W.F.1    Schweizer, R.2
  • 29
    • 0020609789 scopus 로고
    • Pubertal development in Swiss girls
    • Largo RH, Prader A. Pubertal development in Swiss girls. Helv Paediatr Acta. 1983;38:229-243.
    • (1983) Helv Paediatr Acta. , vol.38 , pp. 229-243
    • Largo, R.H.1    Prader, A.2
  • 30
    • 0020609789 scopus 로고
    • Pubertal development in Swiss boys
    • Largo RH, Prader A. Pubertal development in Swiss boys. Helv Paediatr Acta. 1983;38:211-228.
    • (1983) Helv Paediatr Acta. , vol.38 , pp. 211-228
    • Largo, R.H.1    Prader, A.2
  • 31
    • 10544252272 scopus 로고    scopus 로고
    • Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone
    • van Teunenbroek A, de Muinck Keizer-Schrama SM, Stijnen T, et al. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone. J Clin Endocrinol Metab. 1996;81:4013-4021.
    • (1996) J Clin Endocrinol Metab. , vol.81 , pp. 4013-4021
    • Van Teunenbroek, A.1    De Muinck Keizer-Schrama, S.M.2    Stijnen, T.3
  • 32
    • 3242699910 scopus 로고    scopus 로고
    • Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: A randomized, double-blind, placebo-controlled trial
    • Leschek EW, Rose SR, Yanovski JA, et al. Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 2004;89:3140-3148.
    • (2004) J Clin Endocrinol Metab. , vol.89 , pp. 3140-3148
    • Leschek, E.W.1    Rose, S.R.2    Yanovski, J.A.3
  • 33
    • 24344452449 scopus 로고    scopus 로고
    • Efficacy and safety results of long-term growth hormone treatment of idiopathic short stature
    • Kemp SF, Kuntze J, Attie KM, et al. Efficacy and safety results of long-term growth hormone treatment of idiopathic short stature. J Clin Endocrinol Metab. 2005;90:5247-5253.
    • (2005) J Clin Endocrinol Metab. , vol.90 , pp. 5247-5253
    • Kemp, S.F.1    Kuntze, J.2    Attie, K.M.3
  • 34
    • 59749086990 scopus 로고    scopus 로고
    • Height gains in response to growth hormone treatment to final height are similar in patients withSHOX deficiency and Turner syndrome
    • Blum WF, Cao D, Hesse V, et al. Height gains in response to growth hormone treatment to final height are similar in patients withSHOX deficiency and Turner syndrome. Horm Res. 2009;71:167-172.
    • (2009) Horm Res. , vol.71 , pp. 167-172
    • Blum, W.F.1    Cao, D.2    Hesse, V.3
  • 35
    • 75149185822 scopus 로고    scopus 로고
    • Effectiveness of the combined recombinant human growth hormone and gonadotropinreleasing hormone analog therapy in pubertal patients with short stature due to SHOX deficiency
    • Scalco RC, Melo SS, Pugliese-Pires PN, et al. Effectiveness of the combined recombinant human growth hormone and gonadotropinreleasing hormone analog therapy in pubertal patients with short stature due to SHOX deficiency. J Clin Endocrinol Metab. 2010; 95:328-332.
    • (2010) J Clin Endocrinol Metab. , vol.95 , pp. 328-332
    • Scalco, R.C.1    Melo, S.S.2    Pugliese-Pires, P.N.3
  • 36
    • 79551643726 scopus 로고    scopus 로고
    • Non-compliance with growth hormone treatment in children iscommonand impairs linear growth
    • Cutfield WS, Derraik JG, Gunn AJ, et al. Non-compliance with growth hormone treatment in children iscommonand impairs linear growth. PLoS One. 2011;6:e16223.
    • (2011) PLoS One. , vol.6
    • Cutfield, W.S.1    Derraik, J.G.2    Gunn, A.J.3
  • 37
    • 12244312786 scopus 로고    scopus 로고
    • Mesomelic and rhizomelic short stature: The phenotype of combined Leri-Weill dyschondrosteosis and achondroplasia or hypochondroplasia
    • Ross JL, Bellus G, Scott CI Jr, Abboudi J, Grigelioniene G, Zinn AR. Mesomelic and rhizomelic short stature: The phenotype of combined Leri-Weill dyschondrosteosis and achondroplasia or hypochondroplasia. Am J Med Genet A. 2003;116A:61-65.
    • (2003) Am J Med Genet A. , vol.116 A , pp. 61-65
    • Ross, J.L.1    Bellus, G.2    Scott Jr., C.I.3    Abboudi, J.4    Grigelioniene, G.5    Zinn, A.R.6
  • 38
    • 84860868965 scopus 로고    scopus 로고
    • IGF1, IGF1R andSHOX mutation analysis in short children born small for gestational age and short children with normal birth size (idiopathic short stature)
    • Caliebe J, Broekman S, Boogaard M, et al. IGF1, IGF1R andSHOX mutation analysis in short children born small for gestational age and short children with normal birth size (idiopathic short stature). Horm Res Paediatr. 2012;77:250-260.
    • (2012) Horm Res Paediatr. , vol.77 , pp. 250-260
    • Caliebe, J.1    Broekman, S.2    Boogaard, M.3
  • 39
    • 58649107149 scopus 로고    scopus 로고
    • Predicting growth in response to growth hormone treatment
    • Ranke MB, Lindberg A. Predicting growth in response to growth hormone treatment. Growth Horm IGF Res. 2009;19:1-11.
    • (2009) Growth Horm IGF Res. , vol.19 , pp. 1-11
    • Ranke, M.B.1    Lindberg, A.2
  • 40
    • 12544257647 scopus 로고    scopus 로고
    • Bone age progression during the first year of growth hormone therapy in prepubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: Analysis of data from KIGS (Pfizer International Growth Database)
    • Darendeliler F, Ranke MB, Bakker B, et al. Bone age progression during the first year of growth hormone therapy in prepubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database). Horm Res. 2005;63:40-47.
    • (2005) Horm Res. , vol.63 , pp. 40-47
    • Darendeliler, F.1    Ranke, M.B.2    Bakker, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.